Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families.

Cancer genetics and cytogenetics - 1 Mar 2006

Lynch Henry T, Snyder Carrie, Lynch Jane F, Karatoprakli Peggy, Trowonou Abdon, Metcalfe Kelly, Narod Steven A, Gong Gordon

Abstract excerpt

Limited attention has been given to the impact of BRCA mutation disclosure on participants' psychological reaction and cancer control compliance. We asked women (290 mutation-positive, 370 mutation-negative) from 84 hereditary breast-ovarian cancer (HBOC) families with known deleterious BRCA mutations to participate in an evaluation regarding cancer prevention recommendations before and after BRCA mutation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Disclosure

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Mammography

Share to Ovarian Neoplasms

Share to Patient Compliance

Share to Ultrasonography

Source

Identifiers

PMID: 16527602
DOI: 10.1016/j.cancergencyto.2005.07.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families.PMID 16527602Read ↗

A descriptive study of BRCA1 testing and reactions to disclosure of test resultsSemantic proximity Read ↗

BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.Semantic proximity Read ↗

An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer.Semantic proximity Read ↗

Do Breast Cancer Patients Tested in the Oncology Care Setting ShareBRCAMutation Results with Family Members and Health Care Providers?Semantic proximity Read ↗

Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result.Semantic proximity Read ↗

Risk management adherence following genetic testing for hereditary cancer syndromes: a Singaporean experience.Semantic proximity Read ↗

Variants of Uncertain Clinical Significance as a Result of <i>BRCA1/2</i> Testing: Impact of an Ambiguous Breast Cancer Risk MessageSemantic proximity Read ↗

BRCA1/2 test results impact risk management attitudes, intentions, and uptake.Semantic proximity Read ↗

Disclosure to the family of breast/ovarian cancer genetic test results: Patient's willingness and associated factorsSemantic proximity Read ↗

Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress.Semantic proximity Read ↗

Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations.Semantic proximity Read ↗

The psychological impact of breast and ovarian cancer preventive options in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.